MIM
LFST icon

MetLife Investment Management’s Lifestance Health LFST Stock Holding History

MetLife Investment Management’s Portfolio LFST Stock Details LFST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$567K Sell
89,023
-3,916
-4% -$27.2K ﹤0.01% 1688
2025
Q4 		$654K Buy
92,939
+13,000
+16% +$78.4K ﹤0.01% 1667
2025
Q3 		$440K Sell
79,939
-4,623
-5% -$22.7K ﹤0.01% 1867
2025
Q2 		$437K Hold
84,562
– – ﹤0.01% 1739
2025
Q1 		$563K Sell
84,562
-1,352
-2% -$10.3K ﹤0.01% 1672
2024
Q4 		$633K Buy
85,914
+5,492
+7% +$39.4K ﹤0.01% 1671
2024
Q3 		$563K Buy
80,422
+10,084
+14% +$60.6K ﹤0.01% 1724
2024
Q2 		$345K Buy
70,338
+13,731
+24% +$82.8K ﹤0.01% 1932
2024
Q1 		$349K Hold
56,607
– – ﹤0.01% 1881
2023
Q4 		$443K Hold
56,607
– – ﹤0.01% 1763
2023
Q3 		$389K Hold
56,607
– – ﹤0.01% 1787
2023
Q2 		$517K Buy
56,607
+14,541
+35% +$121K ﹤0.01% 1670
2023
Q1 		$313K Hold
42,066
– – ﹤0.01% 1932
2022
Q4 		$208K Hold
42,066
– – ﹤0.01% 2226
2022
Q3 		$278K Hold
42,066
– – ﹤0.01% 2076
2022
Q2 		$234K Hold
42,066
– – ﹤0.01% 2203
2022
Q1 		$425K Buy
42,066
+24,446
+139% +$215K ﹤0.01% 1870
2021
Q4 		$168K Hold
17,620
– – ﹤0.01% 2169
2021
Q3 		$255K Buy
+17,620
New +$339K ﹤0.01% 1931

Other funds holding LFST

TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SP
Summit Partners Boston, Massachusetts $670M AUM 6.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SPIG
Silversmith Partners I GP Boston, Massachusetts $39.2M AUM
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

MetLife Investment Management's LFST Position: Q1 2026 in Review

MetLife Investment Management reduced its Lifestance Health (LFST) stake by 4.2% in Q1 2026, selling an estimated $27.2K and leaving 89,023 shares worth $567K. The position accounts for ﹤0.01% of the portfolio, ranked #1688.

MetLife Investment Management first reported a position in LFST in Q3 2021 and has held it in 19 quarters since. The position peaked at $654K in Q4 2025. 228 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

  • MetLife Investment Management held 89,023 shares of Lifestance Health worth $567K as of Q1 2026.
  • MetLife Investment Management sold 3,916 Lifestance Health shares in Q1 2026, an estimated $27.2K.
  • Lifestance Health made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1688 holding.
  • MetLife Investment Management first reported a position in Lifestance Health in Q3 2021 and has held it in 19 quarters since.
  • MetLife Investment Management's Lifestance Health position peaked at $654K in Q4 2025.
  • 228 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.